{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:59:56Z","timestamp":1778327996102,"version":"3.51.4"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"13","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human B-cell lymphomas are frequently associated with specific genetic changes caused by chromosomal translocations that activate proto-oncogenes. For lymphomas of mice expressing murine leukemia virus, mutagenic proviral insertions are thought to play a similar role. Here we report studies designed to determine whether specific retroviral integration sites might be associated with a specific subset of mouse B-cell lymphomas and if the genes associated with these sites are regularly altered in expression. We studied splenic marginal zone lymphomas (MZL) of NFS.V+ mice that are unusual in exhibiting frequent progression from low to high grade, potentially allowing assignment of cancer genes to processes of initiation and progression. We used inverse PCR to clone and analyze 212 retroviral integration sites from 43 MZL at different stages of progression. Sixty-two marked common integration sites and included 31 that had been marked previously. Among the new common integration sites, seven were unique to MZL. Using microarrays and real-time quantitative PCR analysis, we defined differential patterns of gene expression in association with disease progression for Gfi1, Sox4, Brca2, Snf1lk, Nfkb1, Pou2af1, Prdm1, Stat6, and Blnk. Heightened expression of Gfi1 distinguishes MZL from other lymphoma types. The combined use of proviral tagging and analyses of gene expression thus provides a powerful approach to understanding of genes that collaborate in tumorigenesis.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-3885","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T18:40:50Z","timestamp":1127241650000},"page":"4419-4427","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["High-Throughput Retroviral Tagging for Identification of Genes Involved in Initiation and Progression of Mouse Splenic Marginal Zone Lymphomas"],"prefix":"10.1158","volume":"64","author":[{"given":"Min Sun","family":"Shin","sequence":"first","affiliation":[{"name":"1Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, Rockville, Maryland and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torgny N.","family":"Fredrickson","sequence":"additional","affiliation":[{"name":"1Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, Rockville, Maryland and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet W.","family":"Hartley","sequence":"additional","affiliation":[{"name":"1Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, Rockville, Maryland and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"2Mouse Cancer Genetics Program, National Cancer Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Agaki","sequence":"additional","affiliation":[{"name":"2Mouse Cancer Genetics Program, National Cancer Institute, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Herbert C.","family":"Morse","sequence":"additional","affiliation":[{"name":"1Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, Rockville, Maryland and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"2022061620101593700_B1","unstructured":"Rosenberg N, Jolicoeur P. Retroviral pathogenesis   Coffin JM Hughes SH Varmus HE eds. . Retroviruses, 475-586,   Cold Sprimg Harbor Laboratory Press Cold Spring Harbor, NY   \u20081997."},{"key":"2022061620101593700_B2","doi-asserted-by":"crossref","unstructured":"Bedigian HG, Johnson DA, Jenkins NA, Copeland NG, Evans R. Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol, 51:\u2008586-94, \u20081984.","DOI":"10.1128\/jvi.51.3.586-594.1984"},{"key":"2022061620101593700_B3","doi-asserted-by":"crossref","unstructured":"Gilbert DJ, Neumann PE, Taylor BA, Jenkins NA, Copeland NG. Susceptibility of AKXD recombinant inbred mouse strains to lymphomas. J Virol, 67:\u20082083-90, \u20081993.","DOI":"10.1128\/jvi.67.4.2083-2090.1993"},{"key":"2022061620101593700_B4","doi-asserted-by":"crossref","unstructured":"Li J, Shen H, Himmel KL, et al Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet, 23:\u2008348-53, \u20081999.","DOI":"10.1038\/15531"},{"key":"2022061620101593700_B5","doi-asserted-by":"crossref","unstructured":"Hansen GM, Skapura D, Justice MJ. Genetic profile of insertion mutagenesis in mouse leukemias and lymphomas. Genome Res, 10:\u2008237-43, \u20082000.","DOI":"10.1101\/gr.10.2.237"},{"key":"2022061620101593700_B6","doi-asserted-by":"crossref","unstructured":"Copeland NG, Jenkins NA. Myeloid leukemia: disease genes and mouse models   Hiai H Hino O eds. . Animal models of cancer predisposition syndromes, 53-63,   Karger Basel   \u20081999.","DOI":"10.1159\/000062003"},{"key":"2022061620101593700_B7","unstructured":"Ogawa S, Kurokawa M, Tanaka T, et al Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene, 13:\u2008183-91, \u20081996."},{"key":"2022061620101593700_B8","doi-asserted-by":"crossref","unstructured":"Roberts T, Chernova O, Cowell JK. NB45, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 45 neuroblastoma. Hum Mol Genet, 7:\u20081169-78, \u20081998.","DOI":"10.1093\/hmg\/7.7.1169"},{"key":"2022061620101593700_B9","doi-asserted-by":"crossref","unstructured":"Look AT. Oncogenic transcription factors in the human acute leukemias. Science (Wash D C), 278:\u20081059-64, \u20081997.","DOI":"10.1126\/science.278.5340.1059"},{"key":"2022061620101593700_B10","doi-asserted-by":"crossref","unstructured":"Fredrickson TN, Lennert K, Chattopadhyay SK, Morse HC, III, Hartley JW. Splenic marginal zone lymphomas of mice. Am J Pathol, 154:\u2008805-12, \u20081999.","DOI":"10.1016\/S0002-9440(10)65327-8"},{"key":"2022061620101593700_B11","doi-asserted-by":"crossref","unstructured":"Hartley JW, Chattopadhyay SK, Lander MR, et al Accelerated appearance of multiple B cell lymphoma types in NFS\/N mice congenic for ecotropic murine leukemia viruses. Lab Investig, 80:\u2008159-69, \u20082000.","DOI":"10.1038\/labinvest.3780020"},{"key":"2022061620101593700_B12","doi-asserted-by":"crossref","unstructured":"Morse HC, III, Qi CF, Chattopadhyay SK, et al Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res, 8:\u2008719-33, \u20082001.","DOI":"10.1016\/S0145-2126(01)00022-4"},{"key":"2022061620101593700_B13","unstructured":"Ward JM, Tadesse-Heath L, Perkins SN, Chattopadhyay SK, Hursting SD, Morse HC, III. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice. Lab Investig, 1:\u20083-14, \u20081999."},{"key":"2022061620101593700_B14","doi-asserted-by":"crossref","unstructured":"Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev, 197:\u2008192-205, \u20082004.","DOI":"10.1111\/j.0105-2896.2004.0112.x"},{"key":"2022061620101593700_B15","unstructured":"Fredrickson TN, Harris AW. . Atlas of mouse hematopathology,   Harwood Academic Publishers Amsterdam, Netherlands  \u20082000."},{"key":"2022061620101593700_B16","doi-asserted-by":"crossref","unstructured":"Lund AH, Turner G, Trubetskoy A, et al Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet, 32:\u2008160-5, \u20082002.","DOI":"10.1038\/ng956"},{"key":"2022061620101593700_B17","doi-asserted-by":"crossref","unstructured":"Mikkers H, Allen J, Knipscheer P, Romeyn L, Hart A, Berns A. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet, 32:\u2008153-9, \u20082002.","DOI":"10.1038\/ng950"},{"key":"2022061620101593700_B18","doi-asserted-by":"crossref","unstructured":"Suzuki T, Shen H, Akagi K, et al New genes involved in cancer identified by retroviral tagging. Nat Genet, 32:\u2008166-74, \u20082002.","DOI":"10.1038\/ng949"},{"key":"2022061620101593700_B19","doi-asserted-by":"crossref","unstructured":"Mikkers H, Berns A. Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res, 88:\u200853-99, \u20082003.","DOI":"10.1016\/S0065-230X(03)88255-6"},{"key":"2022061620101593700_B20","doi-asserted-by":"crossref","unstructured":"Morse HC, Anver MR, Fredrickson TN, et al Bethesda proposals for classification of lymphoid neoplasms in mice. Blood, 100:\u2008246-58, \u20082002.","DOI":"10.1182\/blood.V100.1.246"},{"key":"2022061620101593700_B21","doi-asserted-by":"crossref","unstructured":"Neil JC, Cameron ER. Retroviral insertion sites and cancer: fountain of all knowledge?. Cancer Cell, 2:\u2008253-5, \u20082002.","DOI":"10.1016\/S1535-6108(02)00158-7"},{"key":"2022061620101593700_B22","doi-asserted-by":"crossref","unstructured":"Schilham MW, Oosterwegel MA, Moerer P, et al Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature (Lond), 380:\u2008711-4, \u20081996.","DOI":"10.1038\/380711a0"},{"key":"2022061620101593700_B23","doi-asserted-by":"crossref","unstructured":"Scheijen B, Jonkers J, Acton D, Berns A. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol, 71:\u20089-16, \u20081997.","DOI":"10.1128\/jvi.71.1.9-16.1997"},{"key":"2022061620101593700_B24","unstructured":"Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene, 12:\u20081789-801, \u20081996."},{"key":"2022061620101593700_B25","doi-asserted-by":"crossref","unstructured":"Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, Moroy T. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene, 17:\u20082661-77, \u20081998.","DOI":"10.1038\/sj.onc.1202191"},{"key":"2022061620101593700_B26","doi-asserted-by":"crossref","unstructured":"Karsunky H, Mende I, Schmidt T, Moroy T. High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells. Oncogene, 21:\u20081571-9, \u20082002.","DOI":"10.1038\/sj.onc.1205216"},{"key":"2022061620101593700_B27","doi-asserted-by":"crossref","unstructured":"Lo WS, Duggan L, Tolga NC, et al Snf1\u2013a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription. Science (Wash D C), 293:\u20081142-6, \u20082001.","DOI":"10.1126\/science.1062322"},{"key":"2022061620101593700_B28","doi-asserted-by":"crossref","unstructured":"Davies AA, Masson JY, McIlwraith MJ, et al Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell, 7:\u2008273-82, \u20082001.","DOI":"10.1016\/S1097-2765(01)00175-7"},{"key":"2022061620101593700_B29","unstructured":"Galieque Zouitina S, Quief S, Hildebrand MP, et al The B cell transcriptional coactivator BOB1\/OBF1 gene fuses to the LAZ3\/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231). Leukemia, 10:\u2008579-87, \u20081996."},{"key":"2022061620101593700_B30","unstructured":"Philp AJ, Campbell IG, Leet C, et al The phosphatidylinositol 3\u2032-kinase p85\u03b1 gene is an oncogene in human ovarian and colon tumors. Cancer Res, 61:\u20087426-39, \u20082001."},{"key":"2022061620101593700_B31","doi-asserted-by":"crossref","unstructured":"Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Investig, 107:\u2008241-6, \u20082001.","DOI":"10.1172\/JCI11991"},{"key":"2022061620101593700_B32","doi-asserted-by":"crossref","unstructured":"Hwang HC, Martins CP, Bronkhorst Y, et al Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci USA, 99:\u200811293-8, \u20082002.","DOI":"10.1073\/pnas.162356099"},{"key":"2022061620101593700_B33","doi-asserted-by":"crossref","unstructured":"Martins CP, Berns A. Loss of P27(Kip1) but Not P21(Cip1) decreases survival and synergizes with Myc in murine lymphomagenesis. EMBO J, 21:\u20083739-48, \u20082002.","DOI":"10.1093\/emboj\/cdf364"},{"key":"2022061620101593700_B34","doi-asserted-by":"crossref","unstructured":"Taddesse-Heath L, Chattopadhyay SK, Dillehay DL, et al Lymphomas and high-level expression of murine leukemia viruses in CFW mice. J Virol, 74:\u20086832-47, \u20082000.","DOI":"10.1128\/JVI.74.15.6832-6837.2000"},{"key":"2022061620101593700_B35","doi-asserted-by":"crossref","unstructured":"Yukawa K, Kikutani H, Inomoto T, et al Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E\u03bc)-myc transgenic mice. J Exp Med, 170:\u2008711-26, \u20081989.","DOI":"10.1084\/jem.170.3.711"},{"key":"2022061620101593700_B36","doi-asserted-by":"crossref","unstructured":"Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (Il-2)-dependent rat T-cell lymphoma lines to Il-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol, 13:\u20081759-68, \u20081993.","DOI":"10.1128\/mcb.13.3.1759-1768.1993"},{"key":"2022061620101593700_B37","doi-asserted-by":"crossref","unstructured":"Grimes HL, Gilks CB, Chan TO, Porter S, Tsichlis PN. The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci USA, 93:\u200814569-73, \u20081996.","DOI":"10.1073\/pnas.93.25.14569"},{"key":"2022061620101593700_B38","doi-asserted-by":"crossref","unstructured":"Zhu J, Guo L, Min B, et al Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity, 16:\u2008733-44, \u20082002.","DOI":"10.1016\/S1074-7613(02)00317-5"},{"key":"2022061620101593700_B39","doi-asserted-by":"crossref","unstructured":"van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E\u03bc-myc transgenic mice by provirus tagging. Cell, 65:\u2008737-52, \u20081991.","DOI":"10.1016\/0092-8674(91)90382-9"},{"key":"2022061620101593700_B40","unstructured":"Haupt Y, Bath M. L, Harris AW, Adams JM. Bmi-1 transgene induces lymphomas and collaborates with Myc in tumorigenesis. Oncogene, 8:\u20083161-4, \u20081993."},{"key":"2022061620101593700_B41","doi-asserted-by":"crossref","unstructured":"Alkema MJ, Jacobs H, Vanlohuizen M, Berns A. Perturbation of B and T cell development and predisposition to lymphomagenesis in E Mu Bmi1 transgenic mice require the Bmi1 ring finger. Oncogene, 15:\u2008899-910, \u20081997.","DOI":"10.1038\/sj.onc.1201262"},{"key":"2022061620101593700_B42","doi-asserted-by":"crossref","unstructured":"Jacobs JJL, Kieboom K, Marino S, Depinho RA, Van Lohuizen M. The Oncogene and polycomb-group gene Bmi-1 regulates cell proliferation and senescence through the Ink4a locus. Nature (Lond), 397:\u2008164-8, \u20081999.","DOI":"10.1038\/16476"},{"key":"2022061620101593700_B43","doi-asserted-by":"crossref","unstructured":"Raaphorst FM, Van Kemenade FJ, Fieret E, et al Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol, 164:\u20081-4, \u20082000.","DOI":"10.4049\/jimmunol.164.1.1"},{"key":"2022061620101593700_B44","doi-asserted-by":"crossref","unstructured":"Geijsen N, Uings IJ, Pals C, et al Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science (Wash D C), 293:\u20081136-48, \u20082001.","DOI":"10.1126\/science.1059157"},{"key":"2022061620101593700_B45","doi-asserted-by":"crossref","unstructured":"Karlsson A, Giuriato S, Tang F, Fung-Weier J, Levan G, Felsher DW. Genomically complex lymphomas undergo sustained tumor regression upon Myc inactivation unless they acquire novel chromosomal translocations. Blood, 101:\u20082797-803, \u20082003.","DOI":"10.1182\/blood-2002-10-3091"},{"key":"2022061620101593700_B46","doi-asserted-by":"crossref","unstructured":"Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science (Wash D C), 300:\u20081749-51, \u20082003.","DOI":"10.1126\/science.1083413"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/13\/4419\/2515689\/zch01304004419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/13\/4419\/2515689\/zch01304004419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T16:27:46Z","timestamp":1655396866000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/13\/4419\/511405\/High-Throughput-Retroviral-Tagging-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":46,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2004,7,1]]},"published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-3885","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6493674.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6493674","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22363368.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22363371","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]}}}